Rainbow posts Q2 growth as expansion advances
pre-market1 source ↓machine-written, see hownot a recommendation
- RAINBOW close
- ₹1,219
- On the day
- +1.83%
- 52-week high
- ₹1,610
- 52-week low
- ₹1,084
Rainbow Childrens Medicare reported higher consolidated revenue and profit for the second quarter, while continuing an acquisition-led expansion and planning a new hospital in Malad. Q2 revenue stood at ₹548.02 cr and profit after tax reached ₹83.89 cr, both above the year-ago quarter. First-half operating cash flow was ₹217.77 cr, providing an internal cash-flow measure for the company’s ongoing expansion plans. 🏥
The period also included the acquisition of a 64% stake in LLP, adding to the company’s hospital-network expansion strategy. The planned Malad hospital gives the healthcare operator a proposed presence in Mumbai’s western suburbs, although the excerpt did not provide the project’s investment value, bed capacity or commissioning timeline. Q2 PAT ₹83.89 cr and the positive operating cash flow support the earnings profile, while the acquisition and new-hospital plan shift attention toward integration and execution.
OI Charts data showed the stock closed at ₹1,219 on 30 Oct 2026, up 1.83% for the session, with volume of 120,703 shares. The recent move remained mixed: the stock gained 0.8% over five sessions but fell 11.2% over 20 sessions. It traded between a 52-week low of ₹1,084 on 23 Mar 2026 and a 52-week high of ₹1,610 on 5 Aug 2026. 📈
For traders, the next focus is the company’s detailed interim report and disclosures on the 64% LLP acquisition, including the acquired asset’s contribution and integration costs. Progress on the Malad hospital plan, including approvals, project spending, capacity and expected start date, will determine how quickly the expansion can translate into operating growth. The healthcare sector will also track whether cash generation remains adequate as the network expands. 💼
The results follow a period of share-price consolidation after the August 52-week high. The combination of higher quarterly earnings, strong first-half operating cash flow and expansion initiatives provides fresh company-specific information, but the 20-session decline shows that the market’s recent trend had remained weak despite the latest daily gain.
Source: TradingView, 31 Oct 2026
Not investment advice. For informational purposes only.